Institute of Human Virology Annual Meeting 2005-2010

人类病毒学研究所2005-2010年年会

• 批准号: 7087025
• 负责人: ROBERT C GALLO
• 金额: $ 4.6万
• 依托单位: UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-08-18 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7087025
• 关键词: AIDS; AIDS related neoplasm /cancer; health science research potential; information dissemination; meeting /conference /symposium; minority health professional; travel

For nine years the International Meeting of the Institute of Human Virology (Meeting) has provided a forum for dedicated scientists in the fields of virology, most specifically HIV/AIDS and cancer biology to present new data and exchange ideas and views. The Meeting serves as a unique conference with the following aims: 1. To disseminate the most current research findings within the selected program topics; 2. To critically assess the impact of new findings on future directions for research; 3. To provide a forum for discussion of current and emerging issues; 4. To identify, support, and build the next generation AIDS researcher; 5. To increase participation by women ethnic/racial minorities, and other individuals who have been traditionally under represented in science, yet over represented in the populations impacted most by the disease and to increase participation by individuals from the developing world. The Institute of Human Virology (EHV), with the financial support requested in this application, will accomplish these aims: a) by attracting world renown senior scientists as presenters and participants; b) by carefully organizing each dedicated conference session with theoretically divergent perspectives and ethnically diverse participants; c) by enriching the scientific sessions with an open schedule to foster dialog and interaction between and among investigators; d) by reaching out to and promoting the participation of young investigators in poster sessions and scholarship initiatives, and e) by ensuring that conference results are shared with the broader scientific community through publication of all speaker and poster abstracts. The Meeting is further strengthened by a strictly enforced press policy, one that protects data presented at the Meeting for future peer-reviewed publication. This policy prohibits the members of the press from disclosing any information presented at the Annual Meeting without the permission of the presenter. An estimated 650 scientists and clinicians from around the world are expected to participate in this five-day meeting scheduled for August 29 - September 2, 2005 at the Baltimore Waterfront Marriott. To increase participation by FDA and NIH scientists the meetings in 2006-2009 will be alternate between Bethesda and Baltimore in suitable locations. The Meeting for 2005 will offer a combination of single track and dual track lectures. The incorporation of dual track sessions is a result of feedback from our participants who like some of the more specialized sessions that may not be of interest to the entire group but may not be topics at more general meetings they attend including topics like HTLV. This change also allows for more time to be set aside for oral presentations selected from a call for abstracts. Each conference session opens with a senior scientist's overview presentation on the current base of knowledge in the topic of discussion. This overview provides a basis for evaluation of the data presented by a panel of speakers, each sharing the results of their work. The Annual Meeting Program Committee, responsible for the program content, is encouraged to invite speakers with differing perspectives to stimulate open discussion. Posters are displayed throughout the meeting. One evening is set aside for a reception in the poster area to encourage attendance and interaction. Evening social events are provided to encourage participants to meet with current and potential collaborators, and to talk with presenters. The Annual Meeting Scholarship Initiative provides funds to ensure the participation of promising women, ethnic and racial minorities, and other individuals who have been traditionally underrepresented in science as well as participants from the developing world.

九年来，人类病毒学研究所国际会议（会议）为病毒学领域的科学家提供了一个论坛，特别是艾滋病毒/艾滋病和癌症生物学领域的科学家，以提供新的数据并交流想法和观点。本次会议是一次独特的会议，其目标如下： 1.在选定的项目主题内传播最新的研究成果; 2.批判性地评估新发现对未来研究方向的影响; 3.为讨论当前和新出现的问题提供一个论坛; 4.识别、支持和培养下一代艾滋病研究人员; 5.增加妇女、少数民族/种族以及其他历来在科学领域代表性不足但在受疾病影响最严重的人口中代表性过高的个人的参与，并增加发展中国家个人的参与。 人类病毒学研究所将在本申请所要求的财政支持下实现这些目标：a）吸引世界知名的资深科学家作为演讲者和与会者; B）认真组织每次专门会议，让理论上不同的观点和不同种族的与会者参加; c）通过开放的时间表丰富科学会议，促进研究人员之间的对话和互动;（d）通过接触和促进年轻调查人员参加海报会议， 奖学金倡议，以及e）通过出版所有演讲者和海报摘要，确保与更广泛的科学界分享会议成果。严格执行的新闻政策进一步加强了会议，该政策保护在会议上提交的数据，供今后经同行审查后发表。这项政策禁止新闻界成员未经大会许可披露在年会上提交的任何信息。 主持人。预计来自世界各地的650名科学家和临床医生将参加定于2005年8月29日至9月2日在巴尔的摩海滨万豪酒店举行的为期五天的会议。为了增加FDA和NIH科学家的参与，2006-2009年的会议将在贝塞斯达和巴尔的摩的适当地点轮流举行。 2005年的会议将提供单轨和双轨讲座。双轨会议的合并是我们参与者反馈的结果，他们喜欢一些更专业的会议，这些会议可能不是整个小组感兴趣的，但可能不是他们参加的更一般会议的主题，包括HTLV等主题。这 这一变化还允许留出更多的时间用于从征求摘要中选出的口头报告。每次会议开始时，都有一位资深科学家对讨论主题的现有知识基础进行概述。这一概述为评估一组发言者提出的数据提供了基础，每个发言者都分享了他们的工作成果。鼓励负责计划内容的年会计划委员会 邀请具有不同观点的演讲者来激发公开讨论。会议期间张贴了海报。一个晚上是留出一个招待会在海报区，以鼓励出席和互动。提供晚间社交活动，以鼓励参与者与当前和潜在的合作者会面，并与主持人交谈。年度会议奖学金倡议提供资金，以确保有前途的妇女、少数民族和种族以及传统上在科学领域代表性不足的其他个人以及来自发展中国家的参与者的参与。